[Use of perftoran in complex treatment of acute pancreatitis].
Efficiency of using perftoran in acute pancreatitis was determined by studying the dynamics of the level of lactic acid, ascorbic acid, one of the terminal metabolites of lipid peroxidation--TBA-active products in blood serum. Using perftoran was shown to considerably reduce manifestations of hypoxia and the degree of free radical processes that is evidence of antiischemic effect of perftoran in treatment of acute pancreatitis.
Demin
D B
DB
Tarasenko
V S
VS
Nikonorov
A A
AA
Shchetilin
N A
NA
Afonina
S N
SN
Pavlova
M M
MM
Kornilov
S A
SA
Basov
F V
FV
D001802:Blood Substitutes; D004305:Dose-Response Relationship, Drug; D005466:Fluorocarbons / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D019344:Lactic Acid / Q000097:blood; D010535:Laparoscopy / Q000379:methods*; D010180:Pancreatectomy / Q000379:methods*; D019283:Pancreatitis, Acute Necrotizing / Q000097:blood / Q000175:diagnosis / Q000628:therapy*; D012720:Severity of Illness Index; D013396:Suction / Q000379:methods; D016896:Treatment Outcome
D001802:Blood Substitutes; D005466:Fluorocarbons; D019344:Lactic Acid; C063334:perftoran